Lipidated vaccine against dengue virus infection
US8287880B2 · kind B2 · utility
0Cited by
13References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2010 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Dec 22, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are immunogenic composition, fusion proteins, and related methods for inducing immune response to dengue virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.